Status:

COMPLETED

Improving Functioning in Peripheral Arterial Disease

Lead Sponsor:

Northwestern University

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Cardiovascular Diseases

Peripheral Vascular Diseases

Eligibility:

All Genders

Phase:

NA

Brief Summary

The purpose of this study is to compare the effects of nutrition, a supervised treadmill exercise program, and supervised progressive resistance training program on peripheral arterial disease.

Detailed Description

BACKGROUND: Previous work demonstrates that functional limitations associated with peripheral arterial disease (PAD) are diverse and include slower walking speed, poorer walking endurance, and impair...

Eligibility Criteria

Inclusion

  • 150 peripheral arterial disease patients with and without IC

Exclusion

  • Below or above-knee amputation
  • Wheelchair confinement
  • Inability to walk on a treadmill or inability to perform progressive resistance training
  • Inability to return to the medical center three times weekly for 6 months
  • Walking impairment due to a cause other than PAD
  • Class II New York Heart Association (NYHA) heart failure or angina (heart failure or angina occurring at rest or with minimal exertion)
  • Planned lower extremity revascularization or any other major surgery within 12 months
  • Any increase in anginal symptoms during the previous 6 months or angina at rest
  • Subjects with silent coronary ischemia, defined as ST segment depression greater than or equal to 1 mm during baseline exercise treadmill test without associated chest discomfort, unless they have had a normal perfusion stress test during the previous 6 months
  • Subjects with left-bundle branch block or significant ST-T wave changes on their baseline ECG who do not have a perfusion stress test demonstrating absence of reversible ischemia within the previous 6 months
  • Lower extremity revascularization, major orthopedic surgery, or other major surgery during the previous 3 months
  • Myocardial infarction or coronary artery bypass grafting during the previous 3 months
  • Major medical illnesses that may interfere with subject's ability to complete the interventions and/or follow-up testing
  • Current foot ulcer
  • ABI greater than 0.95
  • Life expectancy less than 12 months
  • Does not speak English
  • Patient is currently involved in another clinical trial
  • Dementia
  • Poorly controlled blood pressure
  • Current significant exercise, defined as exercising three times weekly for 30 minutes with sufficient exertion to produce a sweat or other exercise that is comparable to the exercise interventions offered in our protocol
  • Treatment for cancer (other than non-melanoma skin cancer) during the past 12 months (including radiation therapy, chemotherapy, or surgery)

Key Trial Info

Start Date :

September 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2009

Estimated Enrollment :

156 Patients enrolled

Trial Details

Trial ID

NCT00106327

Start Date

September 1 2003

End Date

March 1 2009

Last Update

July 25 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Northwestern University Feinberg School of Medicine

Chicago, Illinois, United States, 60611-3008